ESC Premium Access

Intensive platelet inhibition - Have we reached the ceiling or are there options for further development?

Presentation

About the speakers

Professor Lars Wallentin

Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala (Sweden)
14 presentations
0 follower

Professor Robert Storey

Department of Cardiovascular Science, University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
17 presentations
1 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Stefan James

Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
32 presentations
0 follower

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
29 presentations
1 follower

5 more presentations in this session

Welcome and Introduction

Speaker: Professor L. Wallentin (Uppsala, SE)

Thumbnail

Manipulating the platelet - Successes and failures

Speaker: Professor R. Storey (Sheffield, GB)

Thumbnail

Changing clinical outcomes with more intensive platelet inhibition

Speaker: Professor C. Cannon (Boston, US)

Thumbnail

Effects in various clinical settings, patient subsets and healthcare realities

Speaker: Professor S. James (Uppsala, SE)

Thumbnail

Summary and close

Speaker: Professor R. Mehran (New York, US)

Thumbnail

Access the full session

Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results? (EBAC Accredited)

Speakers: Professor L. Wallentin, Professor R. Storey, Professor C. Cannon, Professor S. James, Professor R. Mehran...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk